Open AccessTargeting CDK4 and 6 in Cancer Therapy: Emerging Preclinical Insights Related to Abemaciclib
Author(s) -
Seth A. Wander,
Neil A. O’Brien,
Lacey M. Litchfield,
Declan O’Dea,
Claudia Morato Guimaraes,
Dennis J. Slamon,
Shom Goel
Publication year - 2022
Publication title -
the oncologist
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.176
H-Index - 164
eISSN - 1549-490X
pISSN - 1083-7159
DOI - 10.1093/oncolo/oyac138
Subject(s) - medicine , palbociclib , breast cancer , cancer research , pharmacology , cyclin dependent kinase 4 , cyclin dependent kinase , cancer , retinoblastoma protein , kinase , cell cycle , metastatic breast cancer , biology , cyclin dependent kinase 2 , microbiology and biotechnology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom